Altogether, the activation of UPR signaling observed through both WB analysis and proteomics, along with the heightened sensitivity to these drugs, provides solid confirmation of the elevated ER stress levels in ovarian cancer cell lines when HOOK1 levels are reduced. The gene discussed is HOOK1; the disease is ovarian cancer.